Lidocaine 1:100M Anesthetic (Red)

Lidocaine Anesthetic HCl 2%, 1:100k Epinephrine #99168

Lidocaine with Epinephrine 1:50,000 and Lidocaine with Epinephrine 1:100,000 are sterile isotonic solutions containing a local anesthetic agent, Lidocaine Hydrochloride, and a vasoconstrictor, Epinephrine (as bitartrate) and are administered parenterally by injection.

Indications

• Local dental anesthesia by nerve block or infiltration.

Features & benefits

• Lidocaine, when used for infiltration, has an average onset time of less than two minutes and a duration of about 60 minutes. When used for nerve blocks, the average onset time is 2 to 4 minutes and will provide about 90 minutes of pulpal anesthesia.
• No-methylparaben formulation to avoid allergic reactions in sensitive patients.
• 100 percent latex-free components to help reduce allergic responses.
• Terminal sterilization of product/cartridges for safe use.
• Mylar label-covered glass cartridges minimize the risk of a wound in the event of a cartridge breakage.
• Cartridges are packed 10 to a blister tray to avoid glass-to-glass contact, reducing breakage.

Risk information:

• Reactions to Lidocaine are characteristic of those associated with other amide-type local anesthetics. A significant cause of adverse reactions to this group of drugs is excessive plasma levels, which may be due to overdosage, inadvertent intravascular injection or slow metabolic degradation. Lidocaine is contraindicated in patients with a known hypersensitivity to it or any local anesthetic agent of the amide type or to other components of lidocaine solutions. Local anesthetics should be employed only by clinicians who are well versed in diagnosis and management of dose-related toxicity and other acute emergencies which might arise from the block to be employed, and then only after ensuring the immediate availability of oxygen, other resuscitative drugs, cardiopulmonary resuscitative equipment, and the personnel resources needed for proper management of toxic reactions and related emergencies. Lidocaine contains potassium metabisulfite, a sulphite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. Please see the package insert for information on prescribing.